Notably, reduced p53 levels have been demonstrated in whole blood cells from RA patients [37], whereas increased p53 expression in circulating lymphocytes and renal parenchymal cells with activated apoptosis has been shown to be involved in the SLE pathogenesis with a clinical activity correlation [20,21,22,23]. The gene discussed is TP53; the disease is systemic lupus erythematosus.